PART II AND III 2 wpc_partiiandiii.htm PART II AND III Part II & III

 


EXPLANATORY NOTE


Worthy Peer Capital, Inc. has prepared the Pre-Effective Amendment to Form 1-A solely for the purpose of filing Exhibit 15.2 pursuant to Rule 252(d).


PART III — EXHIBITS

Index to Exhibits


Exhibit Number

 

Description

2.1††

 

Certificate of Incorporation of Worthy Peer Capital, Inc., filed with the Delaware Secretary of State on June 9, 2016.

2.2††

 

Bylaws of Worthy Peer Capital, Inc.

3.1††

 

Form of Worthy Peer Capital Bond.

3.2††

 

Worthy Bond Investor Agreement

11.1††

 

Consent of Independent Auditors.

11.2††

 

Consent of the Pearlman Law Group LLP (Contained in Exhibit 12.1).

12.1††

 

Opinion of the Pearlman Law Group LLP.

15.1††

 

Non-public correspondence previously submitted.

15.2

 

Response letters to SEC comment letters.

———————

† Filed herewith.

†† Previously filed.







 


SIGNATURES


Pursuant to the requirements of Regulation A, the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form 1-A and has duly caused this offering statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boca Raton, State of Florida, on the 22nd day of December 2017.


 

WORTHY PEER CAPITAL, INC.

 

 

 

 

By:

/s/ Sally Outlaw

 

Name:

Sally Outlaw

 

Title:

Chief Executive Officer


This offering statement has been signed by the following persons, in the capacities, and on the dates indicated.


Name and Signature

 

 

Title

 

 

Date

 

 

 

 

 

 

 

 

 

/s/ Sally Outlaw

 

 

Chief Executive Officer, Director

 

 

December 22, 2017

 

Sally Outlaw

 

 

(Principal Executive Officer)

 

 

 

 

 

 

 

 

 

 

 

 

/s/ Andrew Rachmell

 

 

Senior Vice President, Finance

 

 

December 22, 2017

 

Andrew Rachmell

 

 

(Principal Financial Officer and Principal Accounting Officer)

 

 

 

 

 

 

 

 

 

 

 

 

/s/ Alan Jacobs

 

 

Senior Vice President, Chief Operating Officer, Director

 

 

December 22, 2017

 

Alan Jacobs